Yet, the highly specific PARP1 inhibitor AZD5305 used in our in vitro and in vivo experiments reduced the survival of LIG1-depleted 22Rv1 cells, indicating that PARP1 is the key player in the SL interaction with LIG1 in PCa. Here, LIG1 is linked to posterior cortical atrophy.